Abstract
In contrast to serial injections of recombinant protein, prolonged systemic delivery of proteins derived through in vivo gene transfer may ultimately provide a favorable alternative for long-term therapy of chronic inflammatory diseases such as the predominant use of interferon-beta (IFNβ) in the treatment of multiple sclerosis (MS). In the current study we compared the therapeutic efficacies of electroporation (EP) mediated intramuscular IFNβ gene transfer with repeated alternate day injections of recombinant IFNβ after onset of experimental autoimmune encephalomyelitis (EAE), an animal model widely used in MS research.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
